Agilysys Inc. Files Q3 FY25 10-Q

TL;DR

AGYS Q3 FY25 10-Q filed. Financials look steady.

AI Summary

Agilysys Inc. filed its 10-Q for the period ending December 31, 2024. The filing details financial performance and operational updates for the third quarter of fiscal year 2025. Key financial data and disclosures related to their business operations are presented.

Why It Matters

This filing provides investors with the latest financial performance data for Agilysys Inc., crucial for understanding the company's current health and future prospects.

Risk Assessment

Risk Level: low — This is a routine quarterly filing providing standard financial disclosures.

Key Numbers

• Q3 — Fiscal Quarter (Reporting period for the 10-Q filing.)
• FY2025 — Fiscal Year (The fiscal year to which the Q3 reporting period belongs.)

Key Players & Entities

• AGILYSYS INC (company) — Filer
• 20241231 (date) — Period of Report
• 20250121 (date) — Filing Date
• PIONEER STANDARD ELECTRONICS INC (company) — Former Company Name

FAQ

Filing Documents

• agys-20241231.htm (10-Q) — 2622KB
• agys-ex10_1.htm (EX-10.1) — 67KB
• agys-ex31_1.htm (EX-31.1) — 12KB
• agys-ex31_2.htm (EX-31.2) — 12KB
• agys-ex31_3.htm (EX-31.3) — 11KB
• agys-ex32.htm (EX-32) — 16KB
• img210102116_0.jpg (GRAPHIC) — 10KB
• 0000950170-25-007222.txt ( ) — 7963KB
• agys-20241231.xsd (EX-101.SCH) — 932KB
• agys-20241231_htm.xml (XML) — 1245KB

Financial Information

Part I. Financial Information Item 1

Financial Statements (Unaudited)

Financial Statements (Unaudited) 3 Condensed Consolidated Balance Sheets – December 31, 2024 (Unaudited) and March 31, 2024 3 Condensed Consolidated Statements of Operations (Unaudited) – Three and Nine Months Ended December 31, 2024 and December 31, 2023 4 Condensed Consolidated Statements of Comprehensive Income (Unaudited) – Three and Nine Months Ended December 31, 2024 and December 31, 2023 5 Condensed Consolidated Statements of Cash Flows (Unaudited) – Nine Months Ended December 31, 2024 and December 31, 2023 6 Condensed Consolidated Statements of Shareholders' Equity (Unaudited) – Three and Nine Months Ended December 31, 2024 and December 31, 2023 7 Notes to Condensed Consolidated Financial Statements (Unaudited) 8 Item 2

Management's Discussion and Analysis of Financial Condition and Results of Operations

Management's Discussion and Analysis of Financial Condition and Results of Operations 21 Item 3

Quantitative and Qualitative Disclosures About Market Risk

Quantitative and Qualitative Disclosures About Market Risk 31 Item 4

Controls and Procedures

Controls and Procedures 31

Other Information

Part II. Other Information Item 1

Legal Proceedings

Legal Proceedings 33 Item 1A

Risk Factors

Risk Factors 33 Item 2 Unregistered Sales of Equity Securities and Use of Proceeds 33 Item 3 Defaults Upon Senior Securities 33 Item 4 Mine Safety Disclosures 33 Item 5 Other Information 33 Item 6 Exhibits 34

Signatures

Signatures 35 2 AGILYSYS , INC. CONDENSED CONSOLIDA TED BALANCE SHEETS (In thousands, except share data) December 31, 2024 (Unaudited) March 31, 2024 ASSETS Current assets: Cash and cash equivalents $ 60,761 $ 144,891 Accounts receivable, net of allowance for expected credit losses of $ 937 and $ 974 , respectively 49,275 29,441 Contract assets 4,016 2,287 Inventories 6,360 4,587 Prepaid expenses and other current assets 10,798 7,731 Total current assets 131,210 188,937 Property and equipment, net 16,872 17,930 Operating lease right-of-use assets 17,017 18,384 Goodwill 128,544 32,791 Intangible assets, net 73,539 16,952 Deferred income taxes, non-current 68,041 67,373 Other non-current assets 8,638 8,063 Total assets $ 443,861 $ 350,430 LIABILITIES AND SHAREHOLDERS' EQUITY Current liabilities: Accounts payable $ 11,684 $ 9,422 Contract liabilities 80,338 56,148 Accrued liabilities 17,497 19,522 Operating lease liabilities, current 5,431 4,279 Total current liabilities 114,950 89,371 Deferred income taxes, non-current 11,540 554 Operating lease liabilities, non-current 17,469 19,613 Debt, non-current 38,000 — Other non-current liabilities 5,111 4,415 Commitments and contingencies Shareholders' equity: Common shares, without par value, at $ 0.30 stated value; 80,000,000 shares authorized; 33,342,288 shares issued; and 27,961,890 and 27,376,862 shares outstanding at December 31, 2024 and March 31, 2024, respectively 10,003 10,003 Treasury shares, 5,380,398 and 5,965,426 at December 31, 2024 and March 31, 2024, respectively ( 1,616 ) ( 1,791 ) Capital in excess of stated value 105,017 94,680 Retained earnings 157,055 137,755 Accumulated other comprehensive loss ( 13,668 ) ( 4,170 ) Total shareholders' equity 256,791 236,477 Total liabilities and shareholde

View Full Filing

View this 10-Q filing on SEC EDGAR